(E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide

C22H20N4O4 — CID 20579458

IUPAC(E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide
SMILESO=C(/C=C/c1ccc(CN2C(=O)NC(=O)C2Cc2c[nH]c3ccccc23)cc1)NO
InChIInChI=1S/C22H20N4O4/c27-20(25-30)10-9-14-5-7-15(8-6-14)13-26-19(21(28)24-22(26)29)11-16-12-23-18-4-2-1-3-17(16)18/h1-10,12,19,23,30H,11,13H2,(H,25,27)(H,24,28,29)/b10-9+
InChIKeyAFCHUYQKRXQVEC-MDZDMXLPSA-N
MW404.43 g/mol
LogP2.35
Rot. Bonds6

About (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide

(E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide (PubChem CID 20579458) has the molecular formula C22H20N4O4 and a molecular weight of 404.43 g/mol. Its IUPAC name is (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide.

Molecular Properties

Compound Name(E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide
PubChem CID20579458
Molecular FormulaC22H20N4O4
Molecular Weight404.43 g/mol
Exact Mass404.15
IUPAC Name(E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide
SMILESO=C(/C=C/c1ccc(CN2C(=O)NC(=O)C2Cc2c[nH]c3ccccc23)cc1)NO
InChIInChI=1S/C22H20N4O4/c27-20(25-30)10-9-14-5-7-15(8-6-14)13-26-19(21(28)24-22(26)29)11-16-12-23-18-4-2-1-3-17(16)18/h1-10,12,19,23,30H,11,13H2,(H,25,27)(H,24,28,29)/b10-9+
InChIKeyAFCHUYQKRXQVEC-MDZDMXLPSA-N
XLogP2.35
TPSA114.53 Ų
H-Bond Donors4
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500404.43
LogP ≤ 52.35
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide?
The IUPAC name of (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide (CID 20579458) is (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide.
What is the SMILES notation for (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide?
The canonical SMILES for (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide is O=C(/C=C/c1ccc(CN2C(=O)NC(=O)C2Cc2c[nH]c3ccccc23)cc1)NO.
What is the InChIKey of (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide?
The InChIKey is AFCHUYQKRXQVEC-MDZDMXLPSA-N. The full InChI is InChI=1S/C22H20N4O4/c27-20(25-30)10-9-14-5-7-15(8-6-14)13-26-19(21(28)24-22(26)29)11-16-12-23-18-4-2-1-3-17(16)18/h1-10,12,19,23,30H,11,13H2,(H,25,27)(H,24,28,29)/b10-9+.
What are the key properties of (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide?
(E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide has a molecular weight of 404.43 g/mol, XLogP of 2.35, 6 rotatable bonds, 4 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-N-hydroxy-3-[4-[[5-(1H-indol-3-ylmethyl)-2,4-dioxoimidazolidin-1-yl]methyl]phenyl]prop-2-enamide is sourced from PubChem (CID 20579458), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).